Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta–induced pathology

Authors: Dmytriyeva, Oksana, Belmeguenai, Amor, Bezin, Laurent, Soud, Katia, Drucker Woldbye, David Paul, Gøtzsche, Casper René, Pankratova, Stanislava

Source: In Neurobiology of Aging September 2019 81:88-101

Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Aβ oligomers to rats.

Authors: Baerends, Eva¹ (AUTHOR), Soud, Katia¹ (AUTHOR), Folke, Jonas^2,3 (AUTHOR), Pedersen, Anna-Kathrine⁴ (AUTHOR), Henmar, Simon¹ (AUTHOR), Konrad, Lisa¹ (AUTHOR), Lycas, Matthew D.¹ (AUTHOR), Mori, Yuki⁵ (AUTHOR), Pakkenberg, Bente^2,6 (AUTHOR), Woldbye, David P. D.¹ (AUTHOR), Dmytriyeva, Oksana⁷ (AUTHOR), Pankratova, Stanislava^1,8 (AUTHOR) stasya@sund.ku.dk

Source: Acta Neuropathologica Communications. 8/16/2022, Vol. 10 Issue 1, p1-21. 21p.

Subject Terms: *ALZHEIMER'S disease, *AMYLOID plaque, *MAZE tests, *ENTORHINAL cortex, *COLLECTIVE memory, *RATS, *TAU proteins, *OLIGOMERS

The C‐terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure‐suppressant actions of prepro‐NPY overexpression in male rats.

Authors: Soud, Katia, Jørgensen, Søren Heide, Woldbye, David Paul Drucker, Sørensen, Andreas Toft

Source: Journal of Neuroscience Research; Mar2019, Vol. 97 Issue 3, p362-372, 11p